$254 Thousand is the total value of Knott David M Jr's 154 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APO | New | Apollo Global Management, Inc. | $14,211 | – | 225,000 | +100.0% | 5.58% | – |
| GCVRZ | New | Sanofi | $3,048 | – | 56,000 | +100.0% | 1.20% | – |
| New | Alkermes PLC | $1,804 | – | 64,000 | +100.0% | 0.71% | – | |
| ISEE | New | IVERIC bio, Inc. | $1,581 | – | 65,000 | +100.0% | 0.62% | – |
| SGEN | New | Seagen Inc. | $1,012 | – | 5,000 | +100.0% | 0.40% | – |
| KFT | New | Mondelez International Inc. | $976 | – | 14,000 | +100.0% | 0.38% | – |
| INZY | New | Inozyme Pharma, Inc. | $917 | – | 160,000 | +100.0% | 0.36% | – |
| EOLS | New | Evolus, Inc. | $886 | – | 104,716 | +100.0% | 0.35% | – |
| New | Arcellx Inc | $863 | – | 28,000 | +100.0% | 0.34% | – | |
| New | FaZe Holdings Inc. | $671 | – | 58,321 | +100.0% | 0.26% | – | |
| IBM | New | Int'l Business Machines Corp | $281 | – | 2,142 | +100.0% | 0.11% | – |
| EBC | New | Eastern Bankshares Inc. | $63 | – | 5,000 | +100.0% | 0.02% | – |
| WMT | New | Wal-Mart Stores, Inc. | $33 | – | 225 | +100.0% | 0.01% | – |
| GE | New | General Electric Company | $15 | – | 162 | +100.0% | 0.01% | – |
| New | Kyndryl Holdings Inc. | $6 | – | 428 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Calumet Specialty Products Partners, LP | 11 | Q2 2024 | 31.5% |
| Alphabet Inc-Cl C | 11 | Q2 2024 | 8.2% |
| DocGo, Inc. | 11 | Q2 2024 | 5.8% |
| Ligand Pharmaceuticals Incorporated | 11 | Q2 2024 | 4.3% |
| Pfizer Inc. | 11 | Q2 2024 | 3.2% |
| JPMorgan Chase & Co. | 11 | Q2 2024 | 1.7% |
| Avadel Pharmaceuticals plc | 11 | Q2 2024 | 2.0% |
| Viking Therapeutics, Inc. | 11 | Q2 2024 | 2.9% |
| Vertex Pharmaceuticals, Inc. | 11 | Q2 2024 | 2.1% |
| AllianceBernstein Holdings PL Unit LTD | 11 | Q2 2024 | 0.9% |
View Knott David M Jr's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MIDWEST HOLDING INC.Sold out | December 22, 2023 | 0 | 0.0% |
| Calumet Specialty Products Partners, L.P. | November 08, 2021 | 4,292,200 | 5.4% |
View Knott David M Jr's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-12 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-22 |
| SC 13D/A | 2023-12-22 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
View Knott David M Jr's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.